SCHEMBL7559810

SCHEMBL7559810

OCCc1cccc(-c2ccc(Cl)cc2)c1CO

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CYP2C19 P33261 1/20 0.39
NR4A2 P43354 1/20 0.39
FFAR4 Q5NUL3 2/20 0.37
FFAR1 O14842 1/20 0.37
PDCD1 Q15116 1/20 0.36
CD274 Q9NZQ7 1/20 0.36
NOTUM Q6P988 1/20 0.36
SIRT2 Q8IXJ6 1/20 0.36
SUCNR1 Q9BXA5 2/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
FOLH1 Q04609 2/20 0.35
ADORA2A P29274 1/20 0.35
GCGR P47871 1/20 0.34
PTGS2 P35354 2/20 0.34
PTGS1 P23219 1/20 0.34
GCG P01275 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3746992 0.82 CYP2C19 (0.50) ALDH1A1NPSR1CYP2C19FFAR4FFAR1
SCHEMBL29037321 0.76 CYP2C19 (0.46) CYP2C19NR4A2PDCD1CD274NOTUM
SCHEMBL13824212 0.76 NR4A2 (0.44) CYP2C19NR4A2FFAR4FFAR1PDCD1
SCHEMBL5907399 0.74 FOLH1 (0.49) ALDH1A1FFAR4FFAR1PDCD1CD274
SCHEMBL9988740 0.74 NR4A2 (0.45) CYP2C19NR4A2FFAR4FFAR1PDCD1
SCHEMBL1497158 0.74 CYP2C19 (0.53) CYP2C19NR4A2FFAR4FFAR1PDCD1
SCHEMBL2389062 0.73 NR4A2 (0.44) CYP2C19NR4A2FFAR4FFAR1PDCD1
SCHEMBL1154775 0.71 AHR (0.44) ALDH1A1CYP2C19PDCD1CD274
SCHEMBL2647050 0.71 ALDH1A1 (0.39) ALDH1A1NPSR1CYP2C19FFAR4FFAR1
SCHEMBL5009050 0.71 SLC6A3 (0.55) CYP2C19FFAR4FFAR1SUCNR1SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020111486-A1 Transition metal-cyclopentadienyl-tropane conjugates NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2002-08-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020111486-A1 Transition metal-cyclopentadienyl-tropane conjugates SLC6A3, SLC18A2, SLC6A2 ALDH1A1 231/4885NPSR1 272/4885CYP2C19 616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.